Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

immunization

- PMLiVE

Boehringer links up with Trutino for cancer R&D

Collaboration agreement will focus on cytokine treatments

Delivering change through better rare disease communications

OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes.

OPEN Health

- PMLiVE

No patient left behind

How healthcare comms helps create rare disease communities

- PMLiVE

Biogen bulks up in Alzheimer’s again with $2.7bn Sangamo deal

Gains rights to tau-targeting drug ST-501 as part of broader alliance

- PMLiVE

Acacia finally gets FDA okay for first product Barhemsys

Edison analyst predicts drug could reach $387m at peak

Assessing the value of interim analyses in clinical trials

Why its important and when its needed

- PMLiVE

Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC

Advisory committee voted 6-5 in favour of drug

- PMLiVE

Celgene’s Revlimid scores NICE approval in follicular lymphoma

New ‘chemotherapy-free’ treatment for patients with limited options

- PMLiVE

Bedrock Group bolsters team with three key appointments

Andy Jobson, Deborah Blain and Vicky O'Connor join company

- PMLiVE

Menlo slumps as itching drug fails mid-stage trial

Shares in US biotech closed down almost a third after announcement

- PMLiVE

Trial of Amgen, Servier’s heart failure drug clears interim check

Drug could become a $2bn product if approved

Miranda Dini

AVENIR GLOBAL appoints global healthcare lead

Mirandi Dini expands role at communications firm

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links